Mood symptoms in adult bipolar disorder are associated with increased proinflammatory markers and decreased brain-derived neurotrophic factor (BDNF). We examined serum interleukin-6, high-sensitivity C-reactive protein (hsCRP), and BDNF among 30 bipolar disorder adolescents. Hypomanic/manic symptoms were positively associated with hsCRP. BDNF levels were negatively associated with interleukin-6. Forty percent had cardiovascular high-risk hsCRP levels. Larger longitudinal studies are warranted.
AxelsonD, BirmaherB, StroberM, GillMK, ValeriS, ChiappettaL, RyanN, LeonardH, HuntJ, IyengarS, BridgeJ, KellerM. Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry, 63:1139–1148. 2006.
4.
AxelsonD, BirmaherBJ, BrentD, WassickS, HooverC, BridgeJ, RyanN. A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents. J Child Adolesc Psychopharmacol, 13:463–470. 2003.
5.
BanksWA, FarrSA, MorleyJE. Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation, 10:319–327. 2002.
6.
BanksWA, KastinAJ, BroadwellRD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation, 2:241–248. 1995.
7.
BirmaherB, AxelsonD, GoldsteinB, StroberM, GillMK, HuntJ, HouckP, HaW, IyengarS, KimE, YenS, HowerH, Esposito-SmythersC, GoldsteinT, RyanN, KellerM. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: The Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry, 166:795–804. 2009.
8.
BosettiF, RintalaJ, SeemannR, RosenbergerTA, ContrerasMA, RapoportSI, ChangMC. Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain. Mol Psychiatry, 7:845–850. 2002.
9.
BosettiF, WeerasingheGR, RosenbergerTA, RapoportSI. Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and −2 in rat brain. J Neurochem, 85:690–696. 2003.
10.
BrietzkeE, StertzL, FernandesBS, Kauer-Sant'annaM, MascarenhasM, Escosteguy VargasA, ChiesJA, KapczinskiF. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord, 116:214–217. 2009.
11.
ChambersWJ, Puig-AntichJ, HirschM, PaezP, AmbrosiniPJ, TabriziMA, DaviesM. The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry, 42:696–702. 1985.
12.
CorrellCU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry, 46:687–700. 2007.
13.
DickersonF, StallingsC, OrigoniA, BoronowJ, YolkenR. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry, 31:952–955. 2007.
14.
ElzingaB, MolendijkM, Oude VoshaarR, BusB, PrickaertsJ, SpinhovenP, PenninxB. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology, 214:319–328. 2010.
15.
Evans-LackoSE, ZeberJE, GonzalezJM, OlveraRL. Medical comorbidity among youth diagnosed with bipolar disorder in the United States. J Clin Psychiatry, 70:1461–1466. 2009.
16.
FreyBN, AndreazzaAC, CereserKMM, MartinsMR, ValvassoriSS, ReusGZ, QuevedoJ, KapczinskiF. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci, 79:281–286. 2006.
17.
FreyBN, StanleyJA, NeryFG, MonkulES, NicolettiMA, ChenH-H, HatchJP, CaetanoSC, OrtizO, KapczinskiF, SoaresJC. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: An in vivo 1H MRS study. Bipolar Disord, 9,Suppl 1:119–127. 2007.
18.
GellerB, BadnerJA, TillmanR, ChristianSL, BolhofnerK, CookEHJr.Linkage Disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry, 161:1698–1700. 2004.
GoldsteinBI, FagioliniA, HouckP, KupferDJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord, 11:657–662. 2009a.
21.
GoldsteinBI, KempDE, SoczynskaJK, McIntyreRS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry, 70:1078–1090. 2009b.
22.
GorguluY, CaliyurtO. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Res Bull, 80:158–162. 2009.
23.
GreenlandP, AlpertJS, BellerGA, BenjaminEJ, BudoffMJ, FayadZA, FosterE, HlatkyMA, HodgsonJM, KushnerFG, LauerMS, ShawLJ, SmithSCJr., TaylorAJ, WeintraubWS, WengerNK. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. JACC, 56:2182–2199. 2010.
24.
HamerM, SteptoeA. Association between physical fitness, parasympathetic control, and proinflammatory responses to mental stress. Psychosom Med, 69:660–666. 2007.
25.
HarrisonNA, BrydonL, WalkerC, GrayMA, SteptoeA, CritchleyHD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry, 66:407–414. 2009.
26.
ImhofA, FroehlichM, BrennerH, BoeingH, PepysMB, KoenigW. Effect of alcohol consumption on systemic markers of inflammation. Lancet, 357:763–767. 2001.
27.
IrwinMR, WangM, CampomayorCO, Collado-HidalgoA, ColeS. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med, 166:1756–1762. 2006.
28.
JerrellJM, McIntyreRS, TripathiA. A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. J Clin Psychiatry, 71:1518–1525. 2010.
KapczinskiF, Dal-PizzolF, TeixeiraAL, MagalhaesPVS, Kauer-Sant'AnnaM, KlamtF, de Bittencourt PasqualiMA, QuevedoJ, GamaCS, PostR. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry, 15:784–786. 2010.
31.
KapczinskiF, DiasVV, Kauer-Sant'AnnaM, BrietzkeE, VázquezGH, VietaE, BerkM. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry, 33:1366–1371. 2009.
32.
KapczinskiF, VietaE, AndreazzaAC, FreyBN, GomesFA, TramontinaJ, Kauer-Sant'AnnaM, Grassi-OliveiraR, PostRM. Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neurosci Biobehav Rev, 32:675–692. 2008.
33.
Kauer-Sant'AnnaM, KapczinskiF, AndreazzaAC, BondDJ, LamRW, YoungLT, YathamLN. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol, 12:447–458. 2009.
34.
KaufmanJ, BirmaherB, BrentD, RaoU, FlynnC, MoreciP, WilliamsonD, RyanN. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry, 36:980–988. 1997.
35.
KimY-K, JungH-G, MyintA-M, KimH, ParkS-H. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord, 104:91–95. 2007.
36.
KnijffEM, BreunisMN, van GeestMC, KupkaRW, RuwhofC, de WitHJ, NolenWA, DrexhageHA. A relative resistance of T cells to dexamethasone in bipolar disorder. Bipolar Disord, 8:740–750. 2006.
37.
KraepelinE. Manic-Depressive Insanity and Paranoia. Edinburgh: E.S. Livingstone, 1921.
38.
LangUE, HellwegR, SanderT, GallinatJ. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry, 14:120–122. 2009.
39.
LinP-Y. State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: A meta-analytic study. Neurosci Lett, 466:139–143. 2009.
40.
LovellDJ, GianniniEH, ReiffA, CawkwellGD, SilvermanED, NoctonJJ, SteinLD, GedaliaA, IlowiteNT, WallaceCA, WhitmoreJ, FinckBK. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med, 342:763–769. 2000.
41.
MatsuoK, Walss-BassC, NeryFG, NicolettiMA, HatchJP, FreyBN, MonkulES, Zunta-SoaresGB, BowdenCL, EscamillaMA, SoaresJC. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology, 34:1904–1913. 2009.
42.
McEwenBS. Protective and damaging effects of stress mediators. N Engl J Med, 338:171–179. 1998.
43.
MillerAH, MaleticV, RaisonCL. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry, 65:732–741. 2009.
44.
O'BrienSM, ScullyP, ScottLV, DinanTG. Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients. J Affect Disord, 90:263–267. 2006.
OsbyU, BrandtL, CorreiaN, EkbomA, SparenP. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry, 58:844–850. 2001.
47.
PacificiR, ZuccaroP, PichiniS, RosetPN, PoudevidaS, FarreM, SeguraJ, De la TorreR. Modulation of the immune system in cannabis users. JAMA, 289:1929–1931. 2003.
48.
PadmosRC, HillegersMHJ, KnijffEM, VonkR, BouvyA, StaalFJT, de RidderD, KupkaRW, NolenWA, DrexhageHA. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry, 65:395–407. 2008.
49.
PandeyGN, RizaviHS, DwivediY, PavuluriMN. Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: Effects of treatment and clinical response. J Am Acad Child Adolesc Psychiatry, 47:1077–1085. 2008.
50.
PostRM. Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implications. J Psychiatr Res, 41:979–990. 2007.
51.
RaoJS, HarryGJ, RapoportSI, KimHW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry, 15:384–392. 2010.
52.
RapaportMH, ManjiHK. The effects of lithium on ex vivo cytokine production. Biol Psychiatry, 50:217–224. 2001.
53.
RapoportSI, BosettiF. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?Arch Gen Psychiatry, 59:592–596. 2002.
54.
RasmussenP, BrassardP, AdserH, PedersenMV, LeickL, HartE, SecherNH, PedersenBK, PilegaardH. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol, 94:1062–1069. 2009.
55.
RidkerPM, DanielsonE, FonsecaFAH, GenestJ, GottoAMJr., KasteleinJJP, KoenigW, LibbyP, LorenzattiAJ, MacFadyenJG, NordestgaardBG, ShepherdJ, WillersonJT, GlynnRJ. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med, 359:2195–2207. 2008.
56.
SenS, DumanR, SanacoraG. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol Psychiatry, 64:527–532. 2008.
57.
TangSW, ChuE, HuiT, HelmesteD, LawC. Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects. Neurosci Lett, 431:62–65. 2008.
58.
TiihonenJ, LonnqvistJ, WahlbeckK, KlaukkaT, NiskanenL, TanskanenA, HaukkaJ. 11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study)Lancet, 374:620–627. 2009.
59.
TsuangMT, WoolsonRF, FlemingJA. Causes of death in schizophrenia and manic-depression. Br J Psychiatry, 136:239–242. 1980.
60.
WeekeA, JuelK, VaethM. Cardiovascular death and manic-depressive psychosis. J Affect Disord, 13:287–292. 1987.
61.
WeissmanMM, WickramaratneP, AdamsP, WolkS, VerdeliH, OlfsonM. Brief screening for family psychiatric history: The family history screen. Arch Gen Psychiatry, 57:675–682. 2000.
62.
WerschingH, DuningT, LohmannH, MohammadiS, StehlingC, FobkerM, ContyM, MinnerupJ, RingelsteinEB, BergerK, DeppeM, KnechtS. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology, 74:1022–1029. 2010.
63.
WrightRJ, NewbyDE, StirlingD, LudlamCA, MacdonaldIA, FrierBM. Effects of acute insulin-induced hypoglycemia on indices of inflammation: Putative mechanism for aggravating vascular disease in diabetes. Diabetes Care, 33:1591–1597. 2010.
64.
YasudaS, LiangMH, MarinovaZ, YahyaviA, ChuangDM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry, 14:51–59. 2009.
